Back to Search Start Over

Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine.

Authors :
Strøm, Thea Bismo
Asprusten, Emil
Laerdahl, Jon K.
Øygard, Irene
Hussain, M. Mahmood
Bogsrud, Martin Prøven
Leren, Trond P.
Source :
Journal of Clinical Lipidology; Nov2023, Vol. 17 Issue 6, p800-807, 8p
Publication Year :
2023

Abstract

• Homozygosity for mutation Q384K in the APOB gene causes hypobetalipoproteinemia. • Mutation Q384K disrupts the structure of the large lipid transfer (LLT) module of apoB. • Secretion of apoB-100 from the liver was markedly reduced. • Secretion of apoB-48 from the intestine was normal. • Abnormal structure of LLT module affects lipidation of apoB-100. Molecular genetic testing of patients with hypobetalipoproteinemia may identify a genetic cause that can form the basis for starting proper therapy. Identifying a genetic cause may also provide novel data on the structure-function relationship of the mutant protein. To identify a genetic cause of hypobetalipoproteinemia in a patient with levels of low density lipoprotein cholesterol at the detection limit of 0.1 mmol/l. DNA sequencing of the translated exons with flanking intron sequences of the genes adenosine triphosphate-binding cassette transporter 1, angiopoietin-like protein 3, apolipoprotein B, apolipoprotein A1, lecithin-cholesterol acyltransferase, microsomal triglyceride transfer protein and proprotein convertase subtilisin/kexin type 9. The patient was homozygous for mutation Q384K (c.1150C>A) in the apolipoprotein B gene, and this mutation segregated with hypobetalipoproteinemia in the family. Residue Gln 384 is located in the large lipid transfer module of apoB that has been suggested to be important for lipidation of apolipoprotein B through interaction with microsomal triglyceride transfer protein. Based on measurements of serum levels of triglycerides and apolipoprotein B-48 after an oral fat load, we conclude that the patient was able to synthesize apolipoprotein B-48 in the intestine in a seemingly normal fashion. Our data indicate that mutation Q384K severely reduces the secretion of apolipoprotein B-100 in the liver without reducing the secretion of apolipoprotein B-48 in the intestine. Possible mechanisms for the different effects of this and other missense mutations affecting the large lipid transfer module on the two forms of apoB are discussed. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19332874
Volume :
17
Issue :
6
Database :
Supplemental Index
Journal :
Journal of Clinical Lipidology
Publication Type :
Academic Journal
Accession number :
174103626
Full Text :
https://doi.org/10.1016/j.jacl.2023.08.009